Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 7]
New Report Estimates 10,400 More Māori Should Be On Preventive Treatment For Gout
Wednesday, 8 December 2021, 12:43 pm | PHARMAC
Pharmac has today released the first of a series of reports investigating inequities in medicine access. The report looks specifically at prescribing and dispensing medicines for gout, estimating 10,400 more Māori need preventive treatment each year to achieve ... More >>
Pharmac Negotiates Deal With Pfizer For Its Promising New Oral Antiviral Treatment For COVID-19
Monday, 6 December 2021, 5:34 pm | PHARMAC
Pharmac has negotiated an agreement with the supplier Pfizer for its promising new oral antiviral treatment to treat COVID-19. “Getting vaccinated is the best defence against COVID-19. We are pleased that we have secured an additional treatment to ... More >>
Pharmac Welcomes Interim Report
Thursday, 2 December 2021, 2:08 pm | PHARMAC
Pharmac accepts many of the observations made in the Interim Report and is already making changes to how it operates. “We want to reassure New Zealanders that we are listening,” says chief executive Sarah Fitt. “The transformation of Pharmac ... More >>
Dr Jane Thomas Confirmed As Pharmac’s First Female, Māori Chair Of Expert Advisory Committee
Friday, 26 November 2021, 12:49 pm | PHARMAC
Pharmac’s Chief Executive Sarah Fitt has announced today the appointment of Dr Jane Thomas as Pharmac’s new Chair of the Pharmacology and Therapeutics Advisory Committee (PTAC). <img src="https://img.scoop.co.nz/stories/images/2111/613663b41767fbf9d03a.jpeg" ... More >>
Pharmac Widens Access To Adalimumab Through Transition To Biosimilar
Wednesday, 17 November 2021, 9:13 am | PHARMAC
Pharmac’s chief medical officer Dr David Hughes has today announced the decision to fund a biosimilar adalimumab (Amgevita), improving access to adalimumab for more than 700 New Zealanders. Adalimumab is used to treat a range of rheumatology, gastrointestinal, ... More >>
Pharmac To Fund Baricitinib To Treat Moderate To Severe Cases Of COVID-19
Friday, 5 November 2021, 10:56 am | PHARMAC
Pharmac has purchased another new medicine, baricitinib, to treat moderate to severe cases of COVID-19, with 500 courses expected in New Zealand within a matter of weeks. “Clinical trials have shown baricitinib can help hospitalised COVID-19 patients, ... More >>
Pharmac Negotiates Deal For A Further COVID-19 Treatment
Sunday, 31 October 2021, 2:06 pm | PHARMAC
Pharmac has negotiated an agreement with pharmaceutical supplier Roche to purchase another COVID-19 treatment. Branded as Ronapreve, it could be used in the prevention and treatment of COVID-19 in New Zealand. Ronapreve belongs to a class of medicines ... More >>
Cystic Fibrosis Medicine Added To Pharmac’s Options For Investment List
Wednesday, 27 October 2021, 7:15 am | PHARMAC
Pharmac has announced that Vertex’s triple combination modulator therapy, known in some countries as Trikafta, has been added to the priority list of medicines it would like to fund. In July this year, pharmaceutical company Vertex applied to Pharmac ... More >>
Pharmac Negotiates Deal For Molnupiravir To Treat COVID-19
Monday, 11 October 2021, 6:17 am | PHARMAC
Pharmac has negotiated an agreement with supplier Merck Sharp & Dohme (MSD) to purchase the antiviral molnupiravir. It will be used to treat New Zealanders with mild to moderate COVID-19 symptoms, subject to the treatment gaining regulatory approval ... More >>
Pharmac funds new treatment for rheumatoid arthritis
Thursday, 16 September 2021, 2:47 pm | PHARMAC
Pharmac has funded upadacitinib tablets as an alternative treatment for New Zealanders with severe rheumatoid arthritis, who are impacted by the tocilizumab stock shortage More >>
Pharmac funds tocilizumab to treat cases of COVID-19
Thursday, 16 September 2021, 2:46 pm | PHARMAC
Pharmac is widening funded access to tocilizumab, an immunosuppressive drug used mainly to treat arthritis, to treat moderate to severe cases of COVID-19, subject to access criteria from 1 October 2021. This means prescribers will not have to make ... More >>
Limiting the impact on Kiwis as API leaves the NZ market
Tuesday, 14 September 2021, 2:28 pm | PHARMAC
Pharmac is working hard to limit the impact on over 1 million Kiwis who currently take funded API Consumer Brands (API) medicines, following their announcement that they are leaving the New Zealand market. API announced in July this year they are ... More >>
Pharmac confirms primidone to stay the same
Tuesday, 7 September 2021, 11:10 am | PHARMAC
Pharmac is pleased to confirm that there will be no change in primidone tablets, a treatment used for the management of seizures and epilepsy. In June Pharmac put out a consultation on the supply of an alternative brand of primidone . “We did ... More >>
New Zealand’s tocilizumab supply to be paused
Monday, 6 September 2021, 1:08 pm | PHARMAC
Pharmac has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New Zealand with product for the next three months, due to massive demand worldwide. “Tocilizumab (Actemra) is an anti-inflammatory ... More >>
Pharmac seeks feedback on a biosimilar brand of adalimumab
Thursday, 26 August 2021, 3:42 pm | PHARMAC
Pharmac is considering awarding principal supply to a biosimilar brand of adalimumab (Amgevita) from 1 February 2022. More >>
Pharmac Commits To Being More Transparent
Wednesday, 28 July 2021, 11:03 am | PHARMAC
For the first time, Pharmac is sharing its priority lists for all funding applications for medicines it has assessed but not yet funded. Pharmac’s Chief Executive Sarah Fitt explains, “Until now, we have not shared what applications were on which list, ... More >>
Pharmac Ensuring Supply Of Prednisolone To Treat Children With RSV
Monday, 19 July 2021, 11:44 am | PHARMAC
Pharmac is working hard to ensure ongoing supply of a critical medicine used to treat RSV, following the outbreak of the respiratory virus in our communities. “Prednisolone is a steroid medication used to treat multiple conditions, including RSV,” says ... More >>
Application For Cystic Fibrosis Medicine Received By Pharmac
Friday, 9 July 2021, 9:59 am | PHARMAC
Pharmac is starting its funding assessment process for a new cystic fibrosis medication after receiving an application from pharmaceutical company Vertex. Vertex has applied for its triple combination modulator therapy medicine to be funded for people aged ... More >>
PHARMAC Is Seeking Views On Declining Funding Applications
Wednesday, 30 June 2021, 9:04 am | PHARMAC
PHARMAC is considering declining 97 inactive medicine funding applications. Previously inactive applications have remained on PHARMAC’s books, despite being unlikely to be approved for funding. This has caused confusion as to if they will be funded ... More >>
PHARMAC Seeking Views On New Brand Of Primidone
Tuesday, 22 June 2021, 4:00 pm | PHARMAC
PHARMAC has reached a provisional agreement with medicine supplier Teva to fund a new brand of primidone which is most commonly used to treat and prevent seizures in people with epilepsy. The current supplier of primidone, Apotex, is discontinuing ... More >>
